Biological Synthesis of Silver Nanoparticles with Aqueous Extract of Azadirachta indica Leaf and Its Antimicrobial Activity on Uropathogenic MDR and ESBL Producing Escherichia coli

preprint OA: closed
Full text JSON View at publisher

Abstract

Background The plethora of Escherichia coli (E. coli) strains that show multidrug resistance (MDR) has risen. The production of extended-spectrum beta-lactamases (ESBL) enzymes has greatly aided in this. There have been speculations on the effectiveness of silver nanoparticles in treating drug-resistant infections. Aim This research aims to utilize Azadirachta indica (neem) leaf extract for the production of silver nanoparticles (AI-AgNPs), considering its medicinal and antimicrobial properties. Additionally, this research intends to evaluate the efficacy of these nanoparticles on resistant E. coli infections. Method The antimicrobial activities and cytotoxicity of silver nanoparticles synthesized using neem leaves extract were tested on MDR and ESBL producing E. coli strains, as well as on Human Embryonic Kidney-293 (HEK-239) cell line, respectively. The characterization of silver nanoparticles was done by UV-Vis Spectrophotometry, Fourier-transform infrared spectrometry (FTIR), Dynamic Light Scattering-Zeta Potential (DLS-Zeta), X-Ray Diffraction (XRD), Scanning Electron Microscope (SEM), Transmission Electron Microscope (TEM), and Energy Dispersive X-Ray Spectroscopy (EDAX). Results The synthesized nanoparticles were spherical, smooth, and stable with an average size of approximately 74 nm. The Minimum inhibitory concentration (MIC) of AI-AgNPs was 9.5 µg/ml, and the Minimum bactericidal concentration (MBC) was 121 µg/ml. The IC50 value for AgNPs was 369 µg/mL for HEK-293 cell line exposure. Conclusion This study showed that the biosynthesis of silver nanoparticles from A. indica extract is highly effective, exhibiting strong antibacterial activity against multidrug-resistant bacteria while exhibiting low toxicity to normal human kidney cells. Hence, biosynthesized silver nanoparticles may be useful as antimicrobial materials for infection control because of their remarkable antibacterial activity.
Full text 2,021 characters · extracted from oa-doi-fallback · 4 sections · click to expand

Abstract

Background The plethora of Escherichia coli (E. coli) strains that show multidrug resistance (MDR) has risen. The production of extended-spectrum beta-lactamases (ESBL) enzymes has greatly aided in this. There have been speculations on the effectiveness of silver nanoparticles in treating drug-resistant infections. Aim This research aims to utilize Azadirachta indica (neem) leaf extract for the production of silver nanoparticles (AI-AgNPs), considering its medicinal and antimicrobial properties. Additionally, this research intends to evaluate the efficacy of these nanoparticles on resistant E. coli infections.

Method

The antimicrobial activities and cytotoxicity of silver nanoparticles synthesized using neem leaves extract were tested on MDR and ESBL producing E. coli strains, as well as on Human Embryonic Kidney-293 (HEK-239) cell line, respectively. The characterization of silver nanoparticles was done by UV-Vis Spectrophotometry, Fourier-transform infrared spectrometry (FTIR), Dynamic Light Scattering-Zeta Potential (DLS-Zeta), X-Ray Diffraction (XRD), Scanning Electron Microscope (SEM), Transmission Electron Microscope (TEM), and Energy Dispersive X-Ray Spectroscopy (EDAX).

Results

The synthesized nanoparticles were spherical, smooth, and stable with an average size of approximately 74 nm. The Minimum inhibitory concentration (MIC) of AI-AgNPs was 9.5 µg/ml, and the Minimum bactericidal concentration (MBC) was 121 µg/ml. The IC50 value for AgNPs was 369 µg/mL for HEK-293 cell line exposure.

Conclusion

This study showed that the biosynthesis of silver nanoparticles from A. indica extract is highly effective, exhibiting strong antibacterial activity against multidrug-resistant bacteria while exhibiting low toxicity to normal human kidney cells. Hence, biosynthesized silver nanoparticles may be useful as antimicrobial materials for infection control because of their remarkable antibacterial activity. Competing Interest Statement The authors have declared no competing interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00